Why Exascale Labs Holdings Inc.’s (XLAB) Stock Is Up 38.97%
As of Friday, October 16, Exascale Labs Holdings Inc.’s XLAB share price has surged by 38.97%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Stock Evaluator: Exascale Labs Holdings Inc. (XLAB)
Exascale Labs Holdings Inc. XLAB
$3.15
0.07
2.11%
October 28, 2026 1:31:29 PM
EST
Volume: 925,982
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Information Technology | IT Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Exascale Labs Holdings Inc. develops and operates AI computer infrastructure platforms. It offers graphics processing unit (GPU) cloud infrastructure, scalable GPU compute deployments, AI-ready data center solutions, system integration, GPU procurement and leasing, and full-stack orchestration. The company is based in Houston, Texas.
Commentary & Analysis
Why Exascale Labs Holdings Inc.’s (XLAB) Stock Is Up 91.54%
As of Friday, October 16, Exascale Labs Holdings Inc.’s XLAB share price has surged by 91.54%, which has investors questioning if this is right time to sell.Omar Beirat
Why Exascale Labs Holdings Inc.’s (XLAB) Stock Is Down 6.53%
As of Thursday, October 15, Exascale Labs Holdings Inc.’s XLAB share price has dipped by 6.53%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Why Exascale Labs Holdings Inc.’s (XLAB) Stock Is Up 6.98%
As of Wednesday, October 14, Exascale Labs Holdings Inc.’s XLAB share price has surged by 6.98%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why Exascale Labs Holdings Inc.’s (XLAB) Stock Is Down 7.00%
As of Tuesday, October 13, Exascale Labs Holdings Inc.’s XLAB share price has dipped by 7.00%, which has investors questioning if this is right time to buy.Michael Rose
Financial Summary
| Share Statistics | XLAB | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $280.9 | $702.6 | 32% |
|
| Shares Out (Mil) | na | 49.8 | na |
|
| Institutional Ownership | na | 73.7% | na |
|
| Float (Mil) | na | 40.5 | na |
|
| Beta | na | 0.93 | na |
|
| Avg Daily Volume (000s) | 34,967 | 639 | 99% |
|
| Price Change (52-week) |
na | 53.8% | na |
|
| Growth | XLAB | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 8.0% | na |
|
| Net Income (5yr) | na | 4.8% | na |
|
| EPS (5yr) | na | 10.8% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (16.2%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | XLAB | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $13 | $669 | 10% |
|
| Net Income (TTM) (Mil) | ($9) | ($1) | 30% |
|
| EPS (TTM) | na | $0.000 | na |
|
| Operating Cash Flow (TTM) (Mil) | ($4) | $52 | 26% |
|
| Net Cash Flow (TTM) (Mil) | na | $1 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $82 | 0% |
|
| Enterprise Value (Q1) (Mil) | $295 | $1,258 | 29% |
|
| Valuation | XLAB | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 1.96 | na |
|
| P/E | na | 21.3 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.6 | na |
|
| Ratios | XLAB | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 16.3% | 34.6% | 16% |
|
| Net Margin | (82.1%) | (0.5%) | 9% |
|
| ROA | (228.1%) | (0.1%) | 2% |
|
| ROE | 89.9% | 3.8% | 96% |
|
| Liabilities to Assets | 353.8% | 54.2% | 100% |
|
| F-Score | 1 | 4 | na |
|
Exascale Labs Holdings Inc. did not pass any screens on 10/27/2026.
